01561nas a2200409 4500000000100000008004100001260001300042653004200055653001000097653001900107653002200126653004200148653001900190653002800209653003000237653001000267653002300277653001600300653001900316653001100335653002700346653001000373653001700383653001200400653000900412653000900421653002200430100001500452700001500467700001500482700001300497245010600510300001000616490000700626520050400633022001401137 2012 d c2012 Sep10aAIDS-Related Opportunistic Infections10aAdult10aAmphotericin B10aAntifungal Agents10aAntiretroviral Therapy, Highly Active10aDermatomycoses10aDiagnosis, Differential10aDrug Therapy, Combination10aGhana10aHIV Seropositivity10aHistoplasma10aHistoplasmosis10aHumans10aImmunocompromised Host10aItaly10aItraconazole10aleprosy10aMale10aSkin10aTreatment Outcome1 aScarlata F1 aImburgia C1 aTrizzino M1 aTitone L00a[Leprosy-like cutaneous presentation of Histoplasma capsulatum infection in an African HIV+ patient]. a211-30 v203 a

Histoplasma capsulatum is an opportunistic dimorphic fungus responsible for most often self-limiting or flu-like infections but potentially lethal in immunocompromised hosts. Histoplasmosis is rare in Europe. We reported a case of disseminated histoplasmosis in an African HIV patient with a leprosy-like primary cutaneous presentation and involvement of lungs, brain, limphnodes and eye. The therapy with liposomial B amphotericin and itraconazole led to a prompt resolution of the symptoms.

 a1124-9390